Teva Pharmaceutical Industries(FRA) TEV

Market Cap€38.22B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€31.20

-0.95%

-0.30Today

Teva Pharmaceutical Industries Financials at a Glance

Market Cap

€38.22B

Revenue (TTM)

€14.87K

Net Income (TTM)

€603.78

EPS (TTM)

€0.51

P/E Ratio

64.04

Dividend

€0.00

Beta (Volatility)

0.05 (Low)

Dividend

€0.00

Beta (Volatility)

0.05 (Low)

Price

€31.20

Volume

877

Open

€31.40

Price

€31.20

Volume

877

Open

€31.40

Previous Close

€31.20

Daily Range

€30.60 - €32.10

52-Week Range

€15.25 - €32.90

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

0.05 (Low)

Price

€31.20

Volume

877

Open

€31.40

Previous Close

€31.20

Daily Range

€30.60 - €32.10

52-Week Range

€15.25 - €32.90

Estimated Earnings Date

N/A

TEV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Industry

Pharmaceuticals

Sector

Health Care

Employees

33,346

CEO

Richard Francis

Website

www.tevapharm.com

TEV Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

9.57%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

1.56%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€38.22B

Shares Outstanding

1.17B

Volume

877

Avg. Volume

1.21K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Teva Pharmaceutical Industries Performance Analysis

Teva Pharmaceutical Industries annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 14,190,645,615	5.8%
2023	2023-12-31	EUR 14,658,934,515	3.3%
2024	2024-12-31	EUR 15,263,145,326	4.1%
2025	2025-12-31	EUR 15,349,404,701	0.6%

Teva Pharmaceutical Industries annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -2.10	N/A
2023	2023-12-31	EUR -0.46	-78.0%
2024	2024-12-31	EUR -1.34	189.9%
2025	2025-12-31	EUR 1.07	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€3.57K

+1.0%

Gross Profit

€1.86K

+1.0%

Gross Margin

52.07%

+1.0%

Market Cap

€38.22B

N/A

Market Cap/Employee

€1.01

N/A

Employees

33,346

N/A

Net Income

-€495.39

-2.0%

EBITDA

€342.30

+0.3%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€17.96K

+7.1%

Total Debt

€14.76K

+1.0%

Accounts Receivable

€3.06K

+1.0%

Inventory

€2.82K

+0.9%

Long Term Debt

€10.82K

+0.7%

Short Term Debt

€3.94K

+10.0%

Return on Assets

1.75%

-4.3%

Return on Invested Capital

-2.20%

+0.4%

Free Cash Flow

€388.12

-0.8%

Operating Cash Flow

€476.95

-1.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About TEV

What is the current price of Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries is trading at €31.20 per share.

What is the 52-week range for Teva Pharmaceutical Industries?

Over the past 52 weeks, Teva Pharmaceutical Industries has traded between €15.25 and €32.90.

How much debt does Teva Pharmaceutical Industries have?

As of the most recent reporting period, Teva Pharmaceutical Industries reported total debt of €14.76B.

How much cash does Teva Pharmaceutical Industries have on hand?

Teva Pharmaceutical Industries reported €3.20B in cash and cash equivalents in its most recent financial results.

What is Teva Pharmaceutical Industries’s dividend yield?

Teva Pharmaceutical Industries does not currently have a dividend yield.

Teva Pharmaceutical Industries(FRA) TEV

Teva Pharmaceutical Industries Financials at a Glance

TEV News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Teva Pharmaceutical Industries

TEV Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Teva Pharmaceutical Industries Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TEV

What is the current price of Teva Pharmaceutical Industries?

What is the 52-week range for Teva Pharmaceutical Industries?

How much debt does Teva Pharmaceutical Industries have?

How much cash does Teva Pharmaceutical Industries have on hand?

What is Teva Pharmaceutical Industries’s dividend yield?

Premium Investing Services